Avista Capital Partners News and M&A Summary, 65 Deals Between 2001 and 2019

In the last 3 years, Avista Capital Partners has acquired 5 companies. It has also invested in 1 other.

Avista Capital Partners’ most common sectors for investment are life science (30%) and medical products (15%). The Firm’s most common investment types include buyout (lbo, mbo, mbi) (35%) and secondary buyout (25%). In total, Avista Capital Partners has invested in 15 US states and 5 different countries. Its largest (disclosed) acquisition occurred in 2008 when it acquired ConvaTec for $4.1B.

In the last 3 years, Avista Capital Partners has exited 4 companies. The Firm’s most common exit type is trade sale (48%). Avista Capital Partners’ largest (disclosed) exit occurred in 2011 when it sold Nycomed Pharma AG for $10.8B.

Join Mergr to view Avista Capital Partners’ full profile and discover more mega-sized private equity firms just like it.

Avista Capital Partners

65 East 55th Street,18th Floor,
New York, New York 10022
United States,

Avista Capital Partners is a private investment firm formed by a group of professionals with roots from DLJ Merchant Banking Partners. Avista makes controlling and minority investments in US based energy, healthcare, and media companies with revenues greater than $25 million. Typical transactions include leverage buyouts, build-ups, and growth capital financings. Avista Capital was formed in 2005 and is based in New York City with an additional office in Houston, Texas.

M&A Summary

Buy vs Sell

Top M&A Advisors

Join Mergr to view the latest updates and news from New York-based Avista Capital Partners.

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 3.8K Private Equity Firms
  • 133K M&A Transactions
  • 142K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.0K M&A Advisors
    (Investment Banks and Law Firms)
  • 37K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.